56.70USD-2.46%Mkt Cap: 115.79B $P/E: 15.881d ago
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovasc…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Cheaper
P/B
Avg
Div Yield
Lower
1M Perf
Avg
$1.07TUSDP/E 42.6
$624.26BUSDP/E 30.0
$461.26BUSDP/E 128.0
$307.10BUSDP/E 21.1
$313.12BUSDP/E 35.7
$278.99BUSDP/E 22.3
$287.55BUSDP/E 28.7
$272.43BUSDP/E 22.1
$268.95BUSDP/E 28.0
$206.99BUSDP/E 11.7
$197.77BUSDP/E 25.5
$160.92BUSDP/E 17.6
$135.19BUSDP/E 18.1
$96.93BUSDP/E 18.8
$86.34BUSDP/E 14.0
$54.65BUSD
$30.78BUSDP/E 22.4
MRV
Marvell Technology, Inc.$25.88BUSDP/E 9.8
$11.38BUSDP/E 22.9
$10.80BUSDP/E 18.8
$10.72BUSDP/E 18.6
$6.71BUSDP/E 14.9
$3.56BUSDP/E 14.6
$2.96BUSDP/E 18.1
$56.76MUSD
$40.13MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FLXN
Horizon Flexible Income ETF—P/E 27.3
ROSE
DocMorris AG—
CELG-RI
Bristol-Myers Squibb Company Ce—
Indicators:|
Key Statistics
Company
Market Cap115.79B $
Enterprise Value153.64B $
Revenue (TTM)48.48B $
Gross Profit34.26B $
Net Income (TTM)7.05B $
Revenue/Share23.82 USD
Last Price56.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees32.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)15.88
P/E (Forward)9.31
PEG1.49
EV/EBITDA8.10
EV/Revenue3.17
P/S2.43
P/B5.86
EPS (TTM)3.57
EPS (Forward)6.19
52W Range
42.5270% of range62.89
52W High62.89 USD
52W Low42.52 USD
Profitability
Gross Margin71.08%
Oper. Margin33.04%
EBITDA Margin39.14%
Profit Margin14.64%
ROE38.19%
ROA7.83%
Growth
Revenue Growth2.60%
Earnings Growth9.20%
Cash Flow & Leverage
Operating CF14.16B $
CapEx (TTM)1.31B $
FCF Margin20.32%
FCF Yield8.51%
Net Debt35.94B $
Net Debt/EBITDA1.89
Balance Sheet
Debt/Equity2.55
Current Ratio1.42
Quick Ratio1.18
Book Value/Sh9.828 USD
Cash/Share5.135 USD
Dividends
Fwd Div Rate2.520 USD
Trail. Div Rate2.500 USD
Div. Yield4.37%
5Y Avg Yield3.96%
Payout Ratio70.03%
Ex-Div DateJul 2, 2026
Pay DateAug 3, 2026
Splits
Last Split1000000:951777
Split DateAug 7, 2001
Analyst Consensus
Rating—
Target (Mean)63.08 USD
Upside (mean)+11.3%
Target Range40.00 USD – 75.00 USD
$40.00+11.3% to mean$75.00
# Analysts25
Ownership
Shares Out.2.04B
Float2.04B
Insiders0.08%
Institutions83.78%
Short Interest
Short Ratio3.5d
Short % Float1.94%
Short % Out.1.94%
Shares Short39.60M
Short (prev mo.)36.72M
Technical
SMA 5057.08 (-0.7%)
SMA 20053.86 (+5.3%)
Beta0.24
S&P 52W Chg20.05%
Avg Vol (30d)9.72M
Avg Vol (10d)16.60M
Technical Indicators
RSI (14)50.3
MACD0.0997
MACD Signal-0.1495
MACD Hist.+0.2491
BB Upper58.69 USD
BB Middle56.30 USD
BB Lower53.91 USD
BB Width8.48%
ATR (14)1.471 USD
Vol Ratio (20d)0.81x